---
title: "NHS National Generic Pharmaceuticals Wave 15a"
ocid: "ocds-h6vhtk-046a2f"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-046a2f"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-046a2f.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-046a2f.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2024-12-18"
---

# NHS National Generic Pharmaceuticals Wave 15a

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-046a2f

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-046a2f)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-046a2f.json)

## Summary

The NHS England has completed a public procurement process titled "NHS National Generic Pharmaceuticals Wave 15a," focusing on pharmaceutical products under the industry category of goods. This procurement is linked to a framework agreement with a potential maximum duration of 48 months, starting on 1st February 2025. The procurement covered several regions across the UK, including CESW, LSNE, NWLN, DNW, DLN, DLS, DNE, DCE, and DSW. The initial agreement period varied across lots, with the longest duration being 28 months. The open procedure procurement method was used for the tender, and it was completed with final contracts signed on 5th November 2024. The tender had multiple lots, including oral products for all regions and hospital-only products for specific regions.

This tender provides substantial opportunities for businesses in the pharmaceutical sector, especially those supplying generic medications. The framework agreement's significant duration and potential for extensions mean stable and ongoing business prospects. The tender's division into lots allows for both large and smaller suppliers, including SMEs, to compete, fostering a diverse supplier base and encouraging new market entrants. Companies with strengths in producing or distributing hospital-specific and oral pharmaceutical products would greatly benefit from participating in such contracts, given the high demand and widespread regional requirements. This procurement initiative can help businesses establish long-term relationships with NHS England and other participating bodies, enhancing their profiles and market share in the healthcare sector.

## Notice

NHS National Generic Pharmaceuticals - Wave 15a.
Offer reference number: CM/PHG/23/5697.
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

CM/PHG/23/5697/01 - Orals (plus non-parenteral) Products:
All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months)

CM/PHG/23/5697/02 - Hospital Only Products:
DNW & DLN: 01/02/2025 to 31/01/2027 (24 months)

CM/PHG/23/5697/03 - Hospital Only Products (Housekeeping):
DLS & DNE: 01/02/2025 to 31/05/2026 (16 months)
DCE & DSW: 01/02/2025 to 30/09/2025 (8 months)

### Lot Information

Lot 1 - CM/PHG/23/5697/01 Orals (plus non-parenteral) Products

Potential periods of call-offs under the framework agreement:

CM/PHG/23/5697/01 - Orals (plus non-parenteral) Products:
All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Lot 2 - CM/PHG/23/5697/02 Hospital Only Products

Potential periods of call-offs under the framework agreement:

CM/PHG/23/5697/02 - Hospital Only Products:
DNW & DLN: 01/02/2025 to 31/01/2027 (24 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Lot 3 - CM/PHG/23/5697/03 Hospital Only Products (Housekeeping)

Potential periods of call-offs under the framework agreement:

CM/PHG/23/5697/03 - Hospital Only Products (Housekeeping):
DLS & DNE: 01/02/2025 to 31/05/2026 (16 months)
DCE & DSW: 01/02/2025 to 30/09/2025 (8 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/040795-2024 |
| Notice type | Planning Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Planning, Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 18 Dec 2024 |
| Submission deadline | 8 Aug 2024 |
| Future notice date | 27 Jun 2024 |
| Award date | 5 Nov 2024 |
| Contract period | 1 Feb 2025 - 31 May 2026 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £806,991,470 |
| Lots value | £806,991,471 |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LEEDS |
| Post town | Leeds |
| Postcode | LS2 7UE |
| Country | England |
| ITL 1 | TLE Yorkshire and The Humber |
| ITL 2 | TLE4 West Yorkshire |
| ITL 3 | TLE42 Leeds |
| Local authority | Leeds |
| Electoral ward | Hunslet & Riverside |
| Westminster constituency | Leeds South |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 114 |
| Supplier names | ABBVIE; ACCORD-UK; AFT PHARMA; AGB PHARMA; AGUETTANT; ALTURIX; AMAROX; AOP ORPHAN; ARCADIA PHARMA LTD T/A ARCADIA MEDICAL; ARISTO PHARMA; ASCEND LABORATORIES; ASPEN PHARMACARE; ASPIRE PHARMA; AVENTIS PHARMA LTD T/A SANOFI; B. BRAUN MEDICAL; BAUSCH + LOMB (PHARMA; BAXTER HEALTHCARE; BEAUMONT PHARMA; BIOCON; BOWMED IBISQUS; BROWN AND BURK; CELIX PHARMA; CHIESI; CIPLA; COLONIS PHARMA; CONSILIENT HEALTH; CORREVIO; CRESCENT PHARMA; CST PHARMA; DAY LEWIS MEDICAL; DESITIN PHARMA; DR.REDDY'S LABORATORIES (UK; DRUGSRUS; ENNOGEN HEALTHCARE; ERAMOL (UK; ESTEVE PHARMACEUTICALS; EVOLAN PHARMA; FARMAK PHARMACEUTICALS; FERRING PHARMACEUTICALS; FLEXIPHARM AUSTRADING; FLYNN PHARMA; FOCUS PHARMACEUTICALS; FONTUS HEALTH; FRESENIUS KABI; G.L. PHARMA; GALVANY PHARMA; GENNISIUM PHARMA; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; GRINDEKS KALCEKS; GRUNENTHAL; HAMELN PHARMA; HIKMA PHARMACEUTICALS; IMMEDICA PHARMA; KENT PHARMA; LIPOMED; LOGIXX PHARMA; LUCANE PHARMA; LUNDBECK; MACLEODS PHARMA; MACURE PHARMA; MANX HEALTHCARE; MARTINDALE PHARMA; MEDAC PHARMA; MEDREICH; MERCK SHARPE AND DOHME (UK; MERCURY PHARMACEUTICALS; MILPHARM LTD/AUROBINBDO PRIMARY; MMEU; MORNINGSIDE PHARMAEUTICALS; MSN LABORATORIES EUROPE; NECESSITY SUPPLIES; NEURAXPHARM; NOVARTIS PHARMACEUTICALS; NOVUMGEN; ORION PHARMA (UK; OTSUKA PHARMACEUTICALS; PANPHARMA; PARI MEDICAL; PERENNIAL PHARMA; PFIZER; PHOENIX LAB; PIERRE FABRE; PIRAMAL CRITICAL CARE; RECORDATI PHARMACEUTICALS; REIG JOFRE; RIVOPHARM; ROMA PHARMACEUTICALS; ROSEMONT PHARMACEUTICALS; ROVI BIOTECH; RPH PHARMACEUTICALS; SANDOZ; SCOPE OPHTHALMICS; SEACROSS PHARMACEUTICALS; SELECTIVE SUPPLIES; SOBI (SWEDISH ORPHAN BIOVITRUM; STIRLING ANGLIAN PHARMACEUTICALS; STRIDES PHARMA; SUN PHARMA; SVP PHARMA; SYNCHRONY; TAKEDA; TETRIS PHARMA LTS; TEVA; THEA PHARMACEUTICALS; THORNTON AND ROSS; TILLOMED LABORATORIES; TORBAY PHARMACEUTICALS; TORRENT PHARMA; VANTAGE PHARMACEUTICALS; VIATRIS UK HEALTHCARE; WAYMADE; WOCKHARDT; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 18 Dec 2024 at 14:37 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/040795-2024
- 4 Jul 2024 at 17:06 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/020509-2024
- 24 May 2024 at 08:11 - Planning - Planning Notice - https://www.find-tender.service.gov.uk/Notice/016400-2024

## Notice URLs

- http://health.atamis.co.uk
- https://health-family.force.com/s/Welcome
- https://supplierregistration.cabinetoffice.gov.uk
- https://www.england.nhs.uk//
- https://www.judiciary.uk/courts-and-tribunals/high-court/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-046a2f. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-046a2f.json.